BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2408Drug Manufacturers - Specialty & Generic
$16.97 +$0.35 (+2.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.00 +0.18%
Open$16.61
Prev close$16.62
Day range$16.53 – $17.04
Volume2.86M
Market cap$3.10B
P/E (TTM)–
Dividend yield–

XERS Stock News

Headlines matching Xeris Pharmaceuticals or the XERS ticker, most recent first.

  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $12Market news · 29 Sep 2026 · Direct mention
  • H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)TipRanks · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $10Market news · 22 Sep 2026 · Direct mention
  • Piper Sandler Maintains Xeris Pharmaceuticals(XERS.US) With Hold Rating, Maintains Target Price $8Market news · 10 Sep 2026 · Direct mention
  • Leerink Partners Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $16 PositiveMarket news · 10 Sep 2026 · Direct mention
  • Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $12 PositiveMarket news · 20 Aug 2026 · Direct mention
  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $12Market news · 8 Jul 2026 · Direct mention
  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy RatingMarket news · 1 Jul 2026 · Direct mention
  • Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $9Market news · 14 May 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Xeris Pharmaceuticals (XERS)TipRanks · 3 Mar 2026 · Direct mention
  • H.C. Wainwright Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $18Market news · 9 Nov 2026 · Direct mention
  • Oppenheimer Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $21 PositiveMarket news · 6 Nov 2026 · Direct mention
  • H.C. Wainwright Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $18 PositiveMarket news · 6 Nov 2026 · Direct mention
  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $18 PositiveMarket news · 6 Nov 2026 · Direct mention
  • Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $18 PositiveMarket news · 11 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on XERS.

Sign in to join the discussion.

Scroll to Top